QI
MR

QS Investors’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

QS Investors’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-58,208
Closed -$1.27M – 2110
2015
Q3 		$1.27M Hold
58,208
– – 0.01% 726
2015
Q2 		$1.66M Buy
+58,208
New +$1.7M 0.02% 652

Other funds holding MR

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
GAM
Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

QS Investors's MR Position: Q4 2015 in Review

QS Investors sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q4 2015, closing a stake of 58,208 shares — an estimated $1.27M sold.

QS Investors first reported a position in MR in Q2 2015 and held it in 2 quarters. The position peaked at $1.66M in Q2 2015. 119 funds tracked by Wall St. Rank hold MR as of Q4 2015.

  • QS Investors reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q4 2015 after selling out during the quarter.
  • QS Investors sold 58,208 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q4 2015, an estimated $1.27M.
  • QS Investors first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2015 and held it in 2 quarters.
  • QS Investors's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $1.66M in Q2 2015.
  • 119 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q4 2015.

Based on QS Investors's 13F filing for Q4 2015, filed 16 Feb 2016.